Skip to main content
SpringerLink
Log in

Viral Infections in Dialysis Patients Part A: Human Immunodeficiency Virus Infection in Dialysis Patients

  • Chapter
Replacement of Renal Function by Dialysis

  • 515 Accesses

Abstract

Some of the important questions for nephrologists providing maintenance hemodialysis (MH) or peritoneal dialysis (PD) to patients with end stage renal disease (ESRD) who are also infected with various viral agents include:

  1. a)

    What is the preferential mode of renal replacement therapy for ESRD patients, if the long-term prognosis is determined by the nature and severity of viral infection?

  2. b)

    What are the different therapeutic strategies to treat these infected patients, such as the deployment of antiviral drugs, immunomodulators, and others, and their adverse effects in patients with compromised renal function?

  3. c)

    What are the combined effects of superimposition of immunosuppression on chronic uremia, maintenance dialysis, renal transplantation, and immunosuppressive therapy, on the natural history of viral disease, especially in patients infected with the human immunodeficiency virus (HIV) which preferentially affects the T cell system?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36 (No 1S): 3S, 1987

    Google Scholar 

  2. 2. 1993 revised classification system for HIV infection and expanded case definition for AIDS among adolescents and adults. MMWR 41 (No RR-17): 1, 1992

    Google Scholar 

  3. Rao TKS, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310: 669, 1984

    Article  PubMed  CAS  Google Scholar 

  4. Gardenswartz MH, Lerner CW, Seligson GR et al.: Renal disease in patients with AIDS: a clinicopathologic study. Clin Nephrol 21: 197, 1984

    PubMed  CAS  Google Scholar 

  5. Pardo V, Aldana M, Colton RM et al.: Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 101: 429, 1984

    PubMed  CAS  Google Scholar 

  6. Rao TKS, Friedman EA, Nicastri AD: The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 316: 1062, 1987

    Article  PubMed  CAS  Google Scholar 

  7. Rao TKS, Friedman EA: AIDS (HIV) associated nephropathy: does it exist? An in-depth review. Am J Nephrol 9: 441, 1989

    PubMed  CAS  Google Scholar 

  8. Rao TKS, Friedman EA: Outcome of severe acute renal failure in patients with the acquired immunodeficiency syndrome. In press

    Google Scholar 

  9. Rao TKS, Berns JS: Acute renal failure in patients with HIV infection. in Renal and urologic aspects of HIV infection, edited by Kimmel PL, Berns JS, New York, Churchill Livingstone. In press

    Google Scholar 

  10. Bourgoignie JJ, Meneses R, Ortiz C, Jaffe D, Pardo V: The clinical spectrum of renal disease associated with human immunodeficiency virus. Am J Kidney Dis 12: 131, 1988

    PubMed  CAS  Google Scholar 

  11. Chander P, Soni A, Suri A, Bhagwat R, Yoo J, Treser G: Renal ultrastructural markers in AIDS-associated nephropathy. Am J Pathol 126: 513, 1987

    PubMed  CAS  Google Scholar 

  12. Chander P, Agarwal A, Soni A, Kim K, Treser G: Renal cytomembranous inclusions in idiopathic renal disease as predictive markers for the acquired immunodeficiency syndrome. Hum Pathol 19: 1060, 1988

    Article  PubMed  CAS  Google Scholar 

  13. Cohen AH, Sun NCJ, Shapshak P, Imagawa DT: Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Modern Pathol 2: 125, 1989

    CAS  Google Scholar 

  14. Kopp JB, Klotman ME, Adler SH et al.: Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci USA 89: 1577, 1992

    Article  PubMed  CAS  Google Scholar 

  15. Kopp JB, Bruggeman LA, Klotman PE: Extracellular matrix gene expression in experimental glomerulonephritis. Curr Opinions Nephrol Hypertension 2: 609, 1993

    Article  CAS  Google Scholar 

  16. Shukla RR, Kumar A, Kimmel PL: Transforming growth factor beta increases the expression of HIV-1 gene in transfected human mesangial cells. Kidney Int 44: 1022, 1993

    Article  PubMed  CAS  Google Scholar 

  17. United States Renal Data System: 1993 annual data report, p 24

    Google Scholar 

  18. ESRD Network of New York: 1992 annual report. July 1993

    Google Scholar 

  19. Tokras JI, Alter MJ, Favero MS, Moyer LA, Bland LA: National Surveillance of dialysis-associated diseases in the United States, 1992. ASAIO J. In press

    Google Scholar 

  20. Rao TKS: Acquired immunodeficiency syndrome human immunodeficiency virus and dialysis. in: International Yearbook of Nephrology 1991, edited by Andreucci VE, Fine LG, Boston, MA, Kluwer Academic publishers, 1990, p 199

    Google Scholar 

  21. Rao TKS: Maintenance dialysis in patients with human immunodeficiency virus infection. Semin Dial 1: 203, 1988

    Article  Google Scholar 

  22. Ortiz C, Meneses R, Jaffe JA Fernandez JA, Perez G, Bourgoignie JJ: Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int 34: 248, 1988

    Article  PubMed  CAS  Google Scholar 

  23. Ribot S, Dean D, Goldblat M, Saavedra M: Prognosis of HIV positive dialysis patients. Kidney Int 37: 315, 1990

    Google Scholar 

  24. Feinfeld DA, Kaplan R, Dressler R, Lynn I: Survival of human immunodeficiency virus-infected patients on maintenance dialysis. Clin Nephrol 32: 221, 1989

    PubMed  CAS  Google Scholar 

  25. Chirgwin K, Rao TKS, Landesman SH: HIV infection in a high prevalence hemodialysis unit. AIDS 3: 731, 1989

    PubMed  CAS  Google Scholar 

  26. Kimmel PL, Umana WO, Simmens SJ, Watson J, Bosch JP: Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end-stage renal disease. Kidney Int 44: 373, 1993

    Article  PubMed  CAS  Google Scholar 

  27. Tebben JA, Rigsby MO, Selwyn PA, Brennan N, Kliger A, Finkelstein FO: Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis. Kidney Int 44: 191, 1993

    Article  PubMed  CAS  Google Scholar 

  28. Campbell J, Markowitz N, Fisher EJ, Cruz C: Continuous ambulatory peritoneal dialysis for the AIDS patient. in Ambulatory Peritoneal dialysis, edited by Avram MM, Giordano C, New York, Plenum Publishing Co, 1990, p 266

    Google Scholar 

  29. Diskin CJ: AIDS-related complex by continuous ambulatory peritoneal dialysis. Nephron 51: 548, 1989

    PubMed  CAS  Google Scholar 

  30. Rubin J: Prevalence of HIV virus among patients undergoing continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 35: 144, 1989

    CAS  Google Scholar 

  31. Baumgartner DD, Arterbery VE, Hale AJ, Gupta RK, Bradley SF: Peritoneal dialysis-associated tuberculous peritonitis in an intravenous drug user with acquired immunodeficiency syndrome. Am J Kidney Dis 14(2): 154, 1989

    PubMed  CAS  Google Scholar 

  32. Dressler R, Peters AT, Lynn RI: Pseudomonal and candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virusinfected patients. Am J Med 86: 787, 1989

    Article  PubMed  CAS  Google Scholar 

  33. Elsey RM, Carson RW, Dubose TD Jr: Pasteurella multocida peritonitis in an HIV-positive patient on continuous cycling peritoneal dialysis. Am J Nephrol 11: 61, 1991

    PubMed  CAS  Google Scholar 

  34. Lewis M, Gorban-Brennan NL, Kliger A, Cooper K, Finkelstein FO: Incidence and spectrum of organisms causing peritonitis in HIV positive patients on CAPD. Adv Perit Dial 6: 136, 1990

    PubMed  CAS  Google Scholar 

  35. Wasser WG, Boyle MJ, Brandon S, Gruber SJ, Winston RV, Feldman NS: HIV positivity does not predispose peritoneal dialysis patients to peritonitis. J Am Soc Nephrol 2: 369, 1991

    Google Scholar 

  36. Correa-Rotter R, Saldivar S, Soto LE, de Leon PS, Pena JC: Recovery of HIV antigen in peritoneal dialysis fluid. Perit Dial Int 10: 67, 1990

    PubMed  CAS  Google Scholar 

  37. Breyer JA, Harbison MA: Isolation of human immunodeficiency virus from peritoneal dialysate. Am J Kidney Dis 21: 23, 1993

    PubMed  CAS  Google Scholar 

  38. Shrivastava D, Delano BG, Lundin P, Rao TKS, Markell M, Friedman EA: Factors affecting survival of HIV+ patients undergoing maintenance hemodialysis. J Am Soc Nephrol 3: 320, 1992

    Article  Google Scholar 

  39. Blum MR, Liao SHT, Good SS, Miranda PD: Pharmacokinetics and bioavailability of Zidovudine in humans. Am J Med 85(Suppl 2A): 189, 1988

    PubMed  CAS  Google Scholar 

  40. Gleason JR Jr, Brier ME: Zidovudine in renal failure. Semin Dial 3: 101, 1990

    Article  Google Scholar 

  41. Paoli I, Dave M, Cohen BD: Pharmacodynamics of zidovudine in patients with end stage renal disease. N Engl J Med 326: 839, 1992

    Article  PubMed  CAS  Google Scholar 

  42. Kremer D, Munar MY, Kohlgepp SJ et al.: Zidovudine pharmacokinetics in five HIV seronegative patients undergoing continuous ambulatory peritoneal dialysis. Pharmacotherapy 12: 56, 1992

    PubMed  CAS  Google Scholar 

  43. Spivak JL, Barnes DC, Fuchs E, Quinn TC: Serum immunoreactive erythropoietin in HIV-infected patients. JAAM 261: 3104, 1989

    Article  CAS  Google Scholar 

  44. Shrivastava D, Rao TKS, Sinert R, Khurana E, Lundin AP, Friedman EA: The efficacy of erythropoietin in HIV infected end stage renal disease patients treated by maintenance hemodialysis. In press

    Google Scholar 

  45. Berns JS, Cohen RM, Rudnick MR, Bennett WM: Renal aspects of antimicrobial therapy for HIV infection. in Renal and urologic aspects of HIV infection, edited by Kimmel PL, Berns JS, New York, Churchill Livingstone. In press

    Google Scholar 

  46. Descamps-Latscha B, Herbelin A: Long-term dialysis and cellular immunity: a critical survey. Kidney Int 43(Suppl 41): S135, 1993

    Google Scholar 

  47. Chatenoud L, Herbelin A, Beaurain G, Descamps-Latscha B: Immune deficiency of the uremic patient. Adv Nephrol 19: 259, 1990

    CAS  Google Scholar 

  48. Van Noesel: Functional and phenotypic evidence for selective loss of memory T cells in asymptomatic HIV infected men. J Clin Invest 86: 293, 1990

    Article  PubMed  Google Scholar 

  49. Pinching AJ: Antibody responses in HIV infection. Clin Exp Immunol 84: 181, 1989

    Google Scholar 

  50. Goldfeld AE, Birch-Limberger K, Schooley RT, Walker BD: HIV-1 infection does not induce tumor necrosis factor-alpha or interferon-beta gene transcription. J Acquir Immune Defic Syndr 4: 41, 1991

    PubMed  CAS  Google Scholar 

  51. Munis JR, Richman DD, Kombluth RS: Human immunodeficiency virus-1 infection of macrophages in vitro neither induces tumor necrosis factor (TNF)/cachectin gene expression nor alters TNF/cachectin induction by lipopolysaccharide. J Clin Invest 85: 591, 1990

    PubMed  CAS  Google Scholar 

  52. Edelbaum DE: No AIDS among patients on dialysis? N Engl J Med 314: 187, 1986

    PubMed  CAS  Google Scholar 

  53. Alter MJ, Favero MS, Moyer LA, Miller JK, Bland LA. National Surveillance of dialysis-associated diseases in the United States, 1988. ASAIO Trans 36: 107, 1990

    Article  PubMed  CAS  Google Scholar 

  54. 54. Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodbome pathogens in health-care settings. MMWR 37: 377, 1988

    Google Scholar 

  55. 55. Guidelines for for prevention of transmission of human immunodeficiency virus and hepatitis B virus to healthcare and public safety workers. MMWR 38 (S-6): 1, 1989

    Google Scholar 

  56. 56. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR 40 (RR-8): 1, 1991

    Google Scholar 

  57. Martin LS, McDougal SJ, Loskoski SL: Disinfection and inactivation of Human T Lymphotropic virus type III/Lymphadenopathy-associated virus. J Infect Dis 152: 39, 1985

    Google Scholar 

  58. Shapshak P, McCoy CB, Rivers JE et ai: Inactivation of human immunodeficiency virus-1 at short time intervals using undiluted bleach. J Acqd Immune Def Synd 6: 218, 1993

    CAS  Google Scholar 

  59. Reiser I, Shapiro W, Porush J: The incidence and epidemiology of human immunodeficiency virus infection in 320 patients treated in an inner city hemodialysis center. Am J Kidney Dis 16: 26, 1990

    PubMed  CAS  Google Scholar 

  60. Perez GO, Ortiz C, De Medina M, Schiff E, Bourgoignie JJ: Lack of transmission of human immunodeficiency virus in chronic hemodialysis patients. Am J Nephrol 8: 123

    Google Scholar 

  61. Assogba U, Park A, Rey MA, Barthelemy A, Rottembourg J, Gluckman JC: Prospective study of HIV 1 seropositive patients in hemodialysis centers. Clin Nephrol 29: 312, 1988

    PubMed  CAS  Google Scholar 

  62. Marcus R, Favero MS, Banerjee S et al.: Prevalence and incidence of human immunodeficiency virus among patients undergoing long-term hemodialysis. Am J Med 90:614, 1991

    PubMed  CAS  Google Scholar 

  63. Berlyne G, Kaczmarek RG, Hamburger S et al.: Seroprevalence of antibodies to the human immunodeficiency virus in dialysis workers: results of a multi-center study. Nephron 62: 441, 1992

    PubMed  CAS  Google Scholar 

  64. Erice A, Rhame FS, Heussner RC, Dunn DL, Balfour HH Jr: Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev Infect Dis 13: 537, 1991

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. SUNY Health Science Center at Brooklyn, 450 Clarkson Ave., Box 52, Brooklyn, NY, 11203-2098, USA

    T. K. Sreepada Rao M.D.

Authors
  1. T. K. Sreepada Rao M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

C. Jacobs C. M. Kjellstrand K. M. Koch J. F. Winchester

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Kluwer Academic Publishers

About this chapter

Cite this chapter

Sreepada Rao, T.K. (1996). Viral Infections in Dialysis Patients Part A: Human Immunodeficiency Virus Infection in Dialysis Patients. In: Jacobs, C., Kjellstrand, C.M., Koch, K.M., Winchester, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-0-585-36947-1_48

Download citation

  • DOI: https://doi.org/10.1007/978-0-585-36947-1_48

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-7923-3610-5

  • Online ISBN: 978-0-585-36947-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation